Israel has allowed use of generic version of patent-protected drug in Israel to treat COVID-19

New York Times: “Israel approved the licensing of a generic version of an HIV drug to treat patients infected with the coronavirus on Thursday, despite doubts about its effectiveness in trials.

The anti-viral drug Kaletra, produced by AbbVie Inc, could be a possible treatment for COVID-19, Israel's Health Ministry said after issuing a preliminary permit.

While AbbVie's patent for Kaletra in Israel ends in 2024, the patent in some other countries, such as India, has expired.

It was the first time the country's attorney general has allowed the use of a generic version of a patent-protected drug in Israel, where there are 529 confirmed coronavirus cases. […]”

Read more.